Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer

Breast cancer (BC) dominates in the structure of cancer morbidity and mortality in women worldwide. Despite the advances made in the treatment of this pathology, there is still a variety of unsolved problems, including those associated with disease progression after radical sur- gical interventions....

Full description

Saved in:
Bibliographic Details
Main Authors: L. V. Bolotina, T. I. Deshkina
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/10
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849403710455676928
author L. V. Bolotina
T. I. Deshkina
author_facet L. V. Bolotina
T. I. Deshkina
author_sort L. V. Bolotina
collection DOAJ
description Breast cancer (BC) dominates in the structure of cancer morbidity and mortality in women worldwide. Despite the advances made in the treatment of this pathology, there is still a variety of unsolved problems, including those associated with disease progression after radical sur- gical interventions. One of the urgent current tasks is to estimate the adequate volume of adjuvant treatment with regard to the biological features of a tumor. Our investigation comparatively analyzed the efficiency of two adjuvant chemotherapy regimens (AT and FAC) in patients with primary operable BC in relation to the immunohistochemical tumor subtype (luminal B, luminal HER, HER-2-positive and triple- negative) and the extent of the disease (N0, N1 and N2–3).
format Article
id doaj-art-cbc62d2c3baf4b0eace54163ef8aeace
institution Kabale University
issn 1994-4098
1999-8627
language Russian
publishDate 2014-07-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj-art-cbc62d2c3baf4b0eace54163ef8aeace2025-08-20T03:37:11ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272014-07-0101424810.17650/1994-4098-2014-0-1-42-4825Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancerL. V. Bolotina0T. I. Deshkina1P.A. Herzen Moscow Oncology Research Institute, Ministry of Health of RussiaP.A. Herzen Moscow Oncology Research Institute, Ministry of Health of RussiaBreast cancer (BC) dominates in the structure of cancer morbidity and mortality in women worldwide. Despite the advances made in the treatment of this pathology, there is still a variety of unsolved problems, including those associated with disease progression after radical sur- gical interventions. One of the urgent current tasks is to estimate the adequate volume of adjuvant treatment with regard to the biological features of a tumor. Our investigation comparatively analyzed the efficiency of two adjuvant chemotherapy regimens (AT and FAC) in patients with primary operable BC in relation to the immunohistochemical tumor subtype (luminal B, luminal HER, HER-2-positive and triple- negative) and the extent of the disease (N0, N1 and N2–3).https://ojrs.abvpress.ru/ojrs/article/view/10breast canceradjuvant chemotherapyimmunohistochemical subtypesdocetaxel
spellingShingle L. V. Bolotina
T. I. Deshkina
Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
Опухоли женской репродуктивной системы
breast cancer
adjuvant chemotherapy
immunohistochemical subtypes
docetaxel
title Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
title_full Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
title_fullStr Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
title_full_unstemmed Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
title_short Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
title_sort results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
topic breast cancer
adjuvant chemotherapy
immunohistochemical subtypes
docetaxel
url https://ojrs.abvpress.ru/ojrs/article/view/10
work_keys_str_mv AT lvbolotina resultsofcombinationtreatmentusingdocetaxelinanadjuvantchemotherapyregimenforresectablebreastcancer
AT tideshkina resultsofcombinationtreatmentusingdocetaxelinanadjuvantchemotherapyregimenforresectablebreastcancer